Annual report
7376.TEDINET S100UZZK
Period2023-10-01 → 2024-09-30
Filed2024-12-25
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed
Key figures · 86
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥1.4bn | 2023-10-01 → 2024-09-30 | Standalone | Net sales |
| Revenue | ¥1.3bn | 2022-10-01 → 2023-09-30 | Standalone | Net sales |
| Revenue | ¥1.1bn | 2021-10-01 → 2022-09-30d | Standalone | Net sales (5-year summary) |
| Revenue | ¥1.1bn | 2020-10-01 → 2021-09-30d | Standalone | Net sales (5-year summary) |
| Revenue | ¥1.0bn | 2019-10-01 → 2020-09-30d | Standalone | Net sales (5-year summary) |
| Operating income | −¥18m | 2023-10-01 → 2024-09-30 | Standalone | Operating income |
| Operating income | ¥67m | 2022-10-01 → 2023-09-30 | Standalone | Operating income |
| Ordinary income | ¥6m | 2023-10-01 → 2024-09-30 | Standalone | Ordinary income |
| Ordinary income | ¥66m | 2022-10-01 → 2023-09-30 | Standalone | Ordinary income |
| Ordinary income | ¥51m | 2021-10-01 → 2022-09-30d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥113m | 2020-10-01 → 2021-09-30d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥45m | 2019-10-01 → 2020-09-30d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | −¥92,000 | 2023-10-01 → 2024-09-30 | Standalone | Income before income taxes |
| Profit before tax | ¥61m | 2022-10-01 → 2023-09-30 | Standalone | Income before income taxes |
| Net income | −¥6m | 2023-10-01 → 2024-09-30 | Standalone | Profit loss |
| Net income | ¥45m | 2022-10-01 → 2023-09-30 | Standalone | Profit loss |
| Net income | ¥32m | 2021-10-01 → 2022-09-30d | Standalone | Net income loss (5-year summary) |
| Net income | ¥76m | 2020-10-01 → 2021-09-30d | Standalone | Net income loss (5-year summary) |
| Net income | ¥31m | 2019-10-01 → 2020-09-30d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥909m | at 2024-09-30 | Standalone | Assets |
| Total assets | ¥915m | at 2023-09-30 | Standalone | Assets |
| Total assets | ¥830m | at 2022-09-30d | Standalone | Total assets (5-year summary) |
| Total assets | ¥813m | at 2021-09-30d | Standalone | Total assets (5-year summary) |
| Total assets | ¥467m | at 2020-09-30d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥268m | at 2024-09-30 | Standalone | Liabilities |
| Total liabilities | ¥268m | at 2023-09-30 | Standalone | Liabilities |
| Net assets / equity | ¥642m | at 2024-09-30 | Standalone | Net assets |
| Net assets / equity | ¥647m | at 2023-09-30 | Standalone | Net assets |
| Net assets / equity | ¥613m | at 2022-09-30d | Standalone | Net assets |
| Net assets / equity | ¥575m | at 2021-09-30d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥210m | at 2020-09-30d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥577m | at 2024-09-30 | Standalone | Cash and deposits |
| Cash and deposits | ¥643m | at 2023-09-30 | Standalone | Cash and deposits |
| Cash & equivalents | ¥577m | at 2024-09-30 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥643m | at 2023-09-30 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥597m | at 2022-09-30d | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥615m | at 2021-09-30d | Standalone | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥264m | at 2020-09-30d | Standalone | Cash and cash equivalents (5-year summary) |
| Operating cash flow | −¥36m | 2023-10-01 → 2024-09-30 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | ¥88m | 2022-10-01 → 2023-09-30 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | −¥627,000 | 2021-10-01 → 2022-09-30d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥135m | 2020-10-01 → 2021-09-30d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥62m | 2019-10-01 → 2020-09-30d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥27m | 2023-10-01 → 2024-09-30 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥45m | 2022-10-01 → 2023-09-30 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥24m | 2021-10-01 → 2022-09-30d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥2m | 2020-10-01 → 2021-09-30d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥10m | 2019-10-01 → 2020-09-30d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥2m | 2023-10-01 → 2024-09-30 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | ¥3m | 2022-10-01 → 2023-09-30 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | ¥6m | 2021-10-01 → 2022-09-30d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥217m | 2020-10-01 → 2021-09-30d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥35m | 2019-10-01 → 2020-09-30d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥-5.24 | 2023-10-01 → 2024-09-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥40.85 | 2022-10-01 → 2023-09-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥29.11 | 2021-10-01 → 2022-09-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥82.99 | 2020-10-01 → 2021-09-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥35.76 | 2019-10-01 → 2020-09-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥39.64 | 2022-10-01 → 2023-09-30 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥28.45 | 2021-10-01 → 2022-09-30d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥78.75 | 2020-10-01 → 2021-09-30d | Standalone | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥577.25 | at 2024-09-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥582.38 | at 2023-09-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥550.42 | at 2022-09-30d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥520.37 | at 2021-09-30d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥243.48 | at 2020-09-30d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 70.6% | at 2024-09-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 70.7% | at 2023-09-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 73.8% | at 2022-09-30d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 70.7% | at 2021-09-30d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 44.9% | at 2020-09-30d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | -0.9% | 2023-10-01 → 2024-09-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.2% | 2022-10-01 → 2023-09-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 5.4% | 2021-10-01 → 2022-09-30d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 19.4% | 2020-10-01 → 2021-09-30d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 15.9% | 2019-10-01 → 2020-09-30d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 1,119,740 | at 2024-09-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,119,740 | at 2023-09-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,113,800 | at 2022-09-30d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,105,520 | at 2021-09-30d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 14,350 | at 2020-09-30d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 232 | at 2024-09-30 | Standalone | Number of employees |
| Employees | 200 | at 2023-09-30 | Standalone | Number of employees |
| Employees | 191 | at 2022-09-30d | Standalone | Number of employees |
| Employees | 173 | at 2021-09-30d | Standalone | Number of employees |
| Employees | 162 | at 2020-09-30d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 55
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | employees | at 2024-09-30 | 1 pure |
| Otherother segments | revenue | 2023-10-01 → 2024-09-30 | ¥3m |
| Otherother segments | revenue external | 2023-10-01 → 2024-09-30 | ¥3m |
| Otherother segments | segment assets | at 2024-09-30 | ¥490,000 |
| Otherother segments | segment profit | 2023-10-01 → 2024-09-30 | −¥21m |
| Reconciling Itemsreconciling | capex | 2023-10-01 → 2024-09-30 | ¥3m |
| Reconciling Itemsreconciling | depreciation | 2023-10-01 → 2024-09-30 | ¥410,000 |
| Reconciling Itemsreconciling | segment assets | at 2024-09-30 | ¥698m |
| Reconciling Itemsreconciling | segment profit | 2023-10-01 → 2024-09-30 | −¥189m |
| Health Care Businessreportable segment | capex | 2023-10-01 → 2024-09-30 | ¥1m |
| Health Care Businessreportable segment | depreciation | 2023-10-01 → 2024-09-30 | ¥227,000 |
| Health Care Businessreportable segment | employees | at 2024-09-30 | 18 pure |
| Health Care Businessreportable segment | revenue | 2023-10-01 → 2024-09-30 | ¥156m |
| Health Care Businessreportable segment | revenue external | 2023-10-01 → 2024-09-30 | ¥156m |
| Health Care Businessreportable segment | segment assets | at 2024-09-30 | ¥35m |
| Health Care Businessreportable segment | segment profit | 2023-10-01 → 2024-09-30 | −¥18m |
| IT Sales Outsourcing Businessreportable segment | capex | 2023-10-01 → 2024-09-30 | ¥6m |
| IT Sales Outsourcing Businessreportable segment | depreciation | 2023-10-01 → 2024-09-30 | ¥5m |
| IT Sales Outsourcing Businessreportable segment | employees | at 2024-09-30 | 205 pure |
| IT Sales Outsourcing Businessreportable segment | revenue | 2023-10-01 → 2024-09-30 | ¥1.2bn |
| IT Sales Outsourcing Businessreportable segment | revenue external | 2023-10-01 → 2024-09-30 | ¥1.2bn |
| IT Sales Outsourcing Businessreportable segment | segment assets | at 2024-09-30 | ¥176m |
| IT Sales Outsourcing Businessreportable segment | segment profit | 2023-10-01 → 2024-09-30 | ¥210m |
| Total Of Reportable Segments And Otherssegment total | capex | 2023-10-01 → 2024-09-30 | ¥7m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2023-10-01 → 2024-09-30 | ¥5m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-10-01 → 2024-09-30 | ¥1.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-10-01 → 2024-09-30 | ¥1.4bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2024-09-30 | ¥212m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-10-01 → 2024-09-30 | ¥171m |
| Otherother segments | revenue | 2022-10-01 → 2023-09-30 | ¥4m |
| Otherother segments | revenue external | 2022-10-01 → 2023-09-30 | ¥4m |
| Otherother segments | segment assets | at 2023-09-30 | ¥434,000 |
| Otherother segments | segment profit | 2022-10-01 → 2023-09-30 | −¥12m |
| Reconciling Itemsreconciling | capex | 2022-10-01 → 2023-09-30 | ¥25m |
| Reconciling Itemsreconciling | depreciation | 2022-10-01 → 2023-09-30 | ¥1m |
| Reconciling Itemsreconciling | segment assets | at 2023-09-30 | ¥749m |
| Reconciling Itemsreconciling | segment profit | 2022-10-01 → 2023-09-30 | −¥184m |
| Health Care Businessreportable segment | capex | 2022-10-01 → 2023-09-30 | ¥189,000 |
| Health Care Businessreportable segment | depreciation | 2022-10-01 → 2023-09-30 | ¥235,000 |
| Health Care Businessreportable segment | revenue | 2022-10-01 → 2023-09-30 | ¥156m |
| Health Care Businessreportable segment | revenue external | 2022-10-01 → 2023-09-30 | ¥156m |
| Health Care Businessreportable segment | segment assets | at 2023-09-30 | ¥25m |
| Health Care Businessreportable segment | segment profit | 2022-10-01 → 2023-09-30 | ¥457,000 |
| IT Sales Outsourcing Businessreportable segment | capex | 2022-10-01 → 2023-09-30 | ¥5m |
| IT Sales Outsourcing Businessreportable segment | depreciation | 2022-10-01 → 2023-09-30 | ¥4m |
| IT Sales Outsourcing Businessreportable segment | revenue | 2022-10-01 → 2023-09-30 | ¥1.1bn |
| IT Sales Outsourcing Businessreportable segment | revenue external | 2022-10-01 → 2023-09-30 | ¥1.1bn |
| IT Sales Outsourcing Businessreportable segment | segment assets | at 2023-09-30 | ¥141m |
| IT Sales Outsourcing Businessreportable segment | segment profit | 2022-10-01 → 2023-09-30 | ¥263m |
| Total Of Reportable Segments And Otherssegment total | capex | 2022-10-01 → 2023-09-30 | ¥5m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2022-10-01 → 2023-09-30 | ¥4m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-10-01 → 2023-09-30 | ¥1.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-10-01 → 2023-09-30 | ¥1.3bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2023-09-30 | ¥166m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-10-01 → 2023-09-30 | ¥251m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 928
| Item | Context | Value | Unit |
|---|---|---|---|
| Average number of temporary workers | CurrentYearInstant_NonConsolidatedMember_CorporateSharedMember | 0 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember | 232 | |
| Average number of temporary workers | CurrentYearInstant_NonConsolidatedMember | 9 | |
| Ratio of female employees in managerial positions metrics of reporting company | CurrentYearInstant_NonConsolidatedMember | 0.333 | |
| All employees calculated based on provisions of article714 item1 of ordinance for enforcement of act on childcare leave caregiver leave and other measures for the welfare of workers caring for children or other family members ratio of male employees taking childcare leave metrics of reporting company | CurrentYearInstant_NonConsolidatedMember | 1.000 | |
| All employees differences in wages between male and female employees metrics of reporting company | CurrentYearInstant_NonConsolidatedMember | 0.779 | |
| Regular employees differences in wages between male and female employees metrics of reporting company | CurrentYearInstant_NonConsolidatedMember | 0.797 | |
| Non regular employees differences in wages between male and female employees metrics of reporting company | CurrentYearInstant_NonConsolidatedMember | 0.523 | |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration | 10204000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E36655-000ITSalesOutsourcingBusinessReportableSegmentMember | 6147000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E36655-000HealthCareBusinessReportableSegmentMember | 1300000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_CorporateSharedMember | 2756000 | JPY |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 1119740 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 1119740 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 1119740 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 1119740 | |
| Number of shares constituting one unit | CurrentYearInstant_OrdinaryShareMember | 100 | |
| Number of shareholders national and local governments | CurrentYearInstant_OrdinaryShareMember | － | |
| Number of shareholders financial institutions | CurrentYearInstant_OrdinaryShareMember | 1 | |
| Number of shareholders financial service providers | CurrentYearInstant_OrdinaryShareMember | 13 | |
| Number of shareholders other corporations | CurrentYearInstant_OrdinaryShareMember | 11 | |
| Number of shareholders foreign investors other than individuals | CurrentYearInstant_OrdinaryShareMember | 7 | |
| Number of shareholders foreign individual investors | CurrentYearInstant_OrdinaryShareMember | 3 | |
| Number of shareholders individuals and others | CurrentYearInstant_OrdinaryShareMember | 398 | |
| Number of shareholders total | CurrentYearInstant_OrdinaryShareMember | 433 | |
| Number of shares held number of units national and local governments | CurrentYearInstant_OrdinaryShareMember | － | |
| Number of shares held number of units financial institutions | CurrentYearInstant_OrdinaryShareMember | 569 | |
| Number of shares held number of units financial service providers | CurrentYearInstant_OrdinaryShareMember | 1749 | |
| Number of shares held number of units other corporations | CurrentYearInstant_OrdinaryShareMember | 980 | |
| Number of shares held number of units foreign investors other than individuals | CurrentYearInstant_OrdinaryShareMember | 157 | |
| Number of shares held number of units foreign individual investors | CurrentYearInstant_OrdinaryShareMember | 9 | |
| Number of shares held number of units individuals and others | CurrentYearInstant_OrdinaryShareMember | 7724 | |
| Number of shares held number of units total | CurrentYearInstant_OrdinaryShareMember | 11188 | |
| Number of shares held shares less than one unit | CurrentYearInstant_OrdinaryShareMember | 940 | |
| Percentage of shareholdings national and local governments | CurrentYearInstant_OrdinaryShareMember | － | |
| Percentage of shareholdings financial institutions | CurrentYearInstant_OrdinaryShareMember | 0.0509 | |
| Percentage of shareholdings financial service providers | CurrentYearInstant_OrdinaryShareMember | 0.1563 | |
| Percentage of shareholdings other corporations | CurrentYearInstant_OrdinaryShareMember | 0.0876 | |
| Percentage of shareholdings foreigners other than individuals | CurrentYearInstant_OrdinaryShareMember | 0.0140 | |
| Percentage of shareholdings foreign individuals | CurrentYearInstant_OrdinaryShareMember | 0.0008 | |
| Percentage of shareholdings individuals and others | CurrentYearInstant_OrdinaryShareMember | 0.6904 | |
| Number of shares held | CurrentYearInstant_No1MajorShareholdersMember | 270200 | |
| Shareholding ratio | CurrentYearInstant_No1MajorShareholdersMember | 0.2430 | |
| Number of shares held | CurrentYearInstant_No2MajorShareholdersMember | 60000 | |
| Shareholding ratio | CurrentYearInstant_No2MajorShareholdersMember | 0.0539 | |
| Number of shares held | CurrentYearInstant_No3MajorShareholdersMember | 56900 | |
| Shareholding ratio | CurrentYearInstant_No3MajorShareholdersMember | 0.0511 | |
| Number of shares held | CurrentYearInstant_No4MajorShareholdersMember | 55400 | |
| Shareholding ratio | CurrentYearInstant_No4MajorShareholdersMember | 0.0498 | |
| Number of shares held | CurrentYearInstant_No5MajorShareholdersMember | 54000 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 13 of 13 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |